Praxis Precision Medicine... (PRAX)
Praxis Precision Medicines Statistics
Share Statistics
Praxis Precision Medicines has 20.16M shares outstanding. The number of shares has increased by 17.86% in one year.
Shares Outstanding | 20.16M |
Shares Change (YoY) | 17.86% |
Shares Change (QoQ) | 8.18% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 18.74M |
Failed to Deliver (FTD) Shares | 63 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.04M, so 10.95% of the outstanding shares have been sold short.
Short Interest | 2.04M |
Short % of Shares Out | 10.95% |
Short % of Float | 11.8% |
Short Ratio (days to cover) | 5.08 |
Valuation Ratios
The PE ratio is -7.54 and the forward PE ratio is -6.39. Praxis Precision Medicines's PEG ratio is 0.17.
PE Ratio | -7.54 |
Forward PE | -6.39 |
PS Ratio | 161.13 |
Forward PS | 1.9 |
PB Ratio | 3.09 |
P/FCF Ratio | -10.46 |
PEG Ratio | 0.17 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Praxis Precision Medicines.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.77, with a Debt / Equity ratio of 0.
Current Ratio | 10.77 |
Quick Ratio | 10.77 |
Debt / Equity | 0 |
Debt / EBITDA | -0.01 |
Debt / FCF | -0.01 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $73.73K |
Profits Per Employee | $-1.58M |
Employee Count | 116 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -29.96% in the last 52 weeks. The beta is 2.77, so Praxis Precision Medicines's price volatility has been higher than the market average.
Beta | 2.77 |
52-Week Price Change | -29.96% |
50-Day Moving Average | 58.97 |
200-Day Moving Average | 61.52 |
Relative Strength Index (RSI) | 35.77 |
Average Volume (20 Days) | 495.05K |
Income Statement
In the last 12 months, Praxis Precision Medicines had revenue of 8.55M and earned -182.82M in profits. Earnings per share was -10.21.
Revenue | 8.55M |
Gross Profit | 8.55M |
Operating Income | -200.16M |
Net Income | -182.82M |
EBITDA | -200.16M |
EBIT | -200.16M |
Earnings Per Share (EPS) | -10.21 |
Balance Sheet
The company has 215.37M in cash and 1.37M in debt, giving a net cash position of 214M.
Cash & Cash Equivalents | 215.37M |
Total Debt | 1.37M |
Net Cash | 214M |
Retained Earnings | -836.74M |
Total Assets | 483.11M |
Working Capital | 366.82M |
Cash Flow
In the last 12 months, operating cash flow was -131.76M and capital expenditures 0, giving a free cash flow of -131.76M.
Operating Cash Flow | -131.76M |
Capital Expenditures | 0 |
Free Cash Flow | -131.76M |
FCF Per Share | -7.36 |
Margins
Gross margin is 100%, with operating and profit margins of -2340.29% and -2137.48%.
Gross Margin | 100% |
Operating Margin | -2340.29% |
Pretax Margin | -2137.48% |
Profit Margin | -2137.48% |
EBITDA Margin | -2340.29% |
EBIT Margin | -2340.29% |
FCF Margin | -1540.48% |
Dividends & Yields
PRAX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for PRAX is $105, which is 182.9% higher than the current price. The consensus rating is "Buy".
Price Target | $105 |
Price Target Difference | 182.9% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Stock Splits
The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:15.
Last Split Date | Nov 29, 2023 |
Split Type | backward |
Split Ratio | 1:15 |
Scores
Altman Z-Score | 8.62 |
Piotroski F-Score | 4 |